Cambiar Investors LLC Has $7.07 Million Stock Position in Maximus, Inc. $MMS

Key Points

• Cambiar Investors LLC has reduced its stake in Maximus, Inc. by 9.1%, selling 10,384 shares, and now holds 103,736 shares valued at approximately $7.07 million.
• A recent report from Wall Street Zen downgraded Maximus from a "buy" to a "hold" rating, indicating a shift in analysts' sentiment about the stock.
• Maximus recently announced a quarterly dividend of $0.30 per share, which is set to be paid on August 31st, representing a dividend yield of 1.4% based on its current share price.

Cambiar Investors LLC lowered its stake in Maximus, Inc. (NYSE:MMS - Free Report) by 9.1% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 103,736 shares of the health services provider's stock after selling 10,384 shares during the period. Cambiar Investors LLC owned 0.18% of Maximus worth $7,074,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also modified their holdings of the company. Caitong International Asset Management Co. Ltd increased its holdings in shares of Maximus by 17,533.3% in the first quarter. Caitong International Asset Management Co. Ltd now owns 529 shares of the health services provider's stock valued at $36,000 after purchasing an additional 526 shares in the last quarter. UMB Bank n.a. increased its holdings in shares of Maximus by 70.2% in the first quarter. UMB Bank n.a. now owns 606 shares of the health services provider's stock valued at $41,000 after purchasing an additional 250 shares in the last quarter. GAMMA Investing LLC increased its holdings in shares of Maximus by 67.1% in the first quarter. GAMMA Investing LLC now owns 732 shares of the health services provider's stock valued at $50,000 after purchasing an additional 294 shares in the last quarter. NBC Securities Inc. increased its holdings in shares of Maximus by 114,900.0% in the first quarter. NBC Securities Inc. now owns 1,150 shares of the health services provider's stock valued at $78,000 after purchasing an additional 1,149 shares in the last quarter. Finally, Blue Trust Inc. increased its holdings in shares of Maximus by 32.8% in the first quarter. Blue Trust Inc. now owns 1,228 shares of the health services provider's stock valued at $84,000 after purchasing an additional 303 shares in the last quarter. Institutional investors and hedge funds own 97.21% of the company's stock.

Insider Activity

In other news, Director Gayathri Rajan sold 7,913 shares of the business's stock in a transaction on Friday, May 30th. The shares were sold at an average price of $72.38, for a total value of $572,742.94. Following the completion of the transaction, the director owned 14,205 shares of the company's stock, valued at $1,028,157.90. The trade was a 35.78% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.60% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen lowered shares of Maximus from a "buy" rating to a "hold" rating in a report on Thursday, May 15th. One equities research analyst has rated the stock with a Buy rating, According to data from MarketBeat.com, the stock currently has a consensus rating of "Buy" and an average target price of $90.00.

Maximus Trading Up 0.2%

MMS traded up $0.1990 during trading on Wednesday, reaching $85.1790. 551,676 shares of the company's stock were exchanged, compared to its average volume of 571,432. The company's fifty day moving average price is $73.58 and its 200-day moving average price is $70.83. The company has a debt-to-equity ratio of 0.91, a quick ratio of 2.27 and a current ratio of 2.27. Maximus, Inc. has a fifty-two week low of $63.77 and a fifty-two week high of $93.94. The firm has a market capitalization of $4.80 billion, a PE ratio of 15.69 and a beta of 0.60.

Maximus (NYSE:MMS - Get Free Report) last released its earnings results on Thursday, August 7th. The health services provider reported $2.16 EPS for the quarter, topping analysts' consensus estimates of $1.39 by $0.77. Maximus had a net margin of 5.83% and a return on equity of 24.44%. The firm had revenue of $1.35 billion during the quarter, compared to analyst estimates of $1.29 billion. During the same quarter in the previous year, the business earned $1.74 EPS. The business's quarterly revenue was up 2.5% compared to the same quarter last year. Maximus has set its FY 2025 guidance at 7.350-7.550 EPS. As a group, equities analysts forecast that Maximus, Inc. will post 6.15 EPS for the current year.

Maximus Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Sunday, August 31st. Stockholders of record on Friday, August 15th will be issued a $0.30 dividend. The ex-dividend date of this dividend is Friday, August 15th. This represents a $1.20 annualized dividend and a dividend yield of 1.4%. Maximus's payout ratio is 22.10%.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.